nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Foetal death—Methotrexate—psoriatic arthritis	0.0543	0.0543	CcSEcCtD
Nalbuphine—Speech impairment NOS—Methotrexate—psoriatic arthritis	0.0287	0.0287	CcSEcCtD
Nalbuphine—Dysgeusia—Auranofin—psoriatic arthritis	0.0138	0.0138	CcSEcCtD
Nalbuphine—Delusion—Methylprednisolone—psoriatic arthritis	0.0134	0.0134	CcSEcCtD
Nalbuphine—Delusion—Betamethasone—psoriatic arthritis	0.0122	0.0122	CcSEcCtD
Nalbuphine—Delusion—Dexamethasone—psoriatic arthritis	0.0122	0.0122	CcSEcCtD
Nalbuphine—Tingling sensation—Methylprednisolone—psoriatic arthritis	0.0118	0.0118	CcSEcCtD
Nalbuphine—Tingling sensation—Betamethasone—psoriatic arthritis	0.0107	0.0107	CcSEcCtD
Nalbuphine—Tingling sensation—Dexamethasone—psoriatic arthritis	0.0107	0.0107	CcSEcCtD
Nalbuphine—Delusion—Prednisone—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Nalbuphine—Dyspepsia—Auranofin—psoriatic arthritis	0.0102	0.0102	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00944	0.00944	CcSEcCtD
Nalbuphine—Wheezing—Triamcinolone—psoriatic arthritis	0.00921	0.00921	CcSEcCtD
Nalbuphine—Pulmonary oedema—Prednisolone—psoriatic arthritis	0.00918	0.00918	CcSEcCtD
Nalbuphine—Urticaria—Auranofin—psoriatic arthritis	0.00917	0.00917	CcSEcCtD
Nalbuphine—Abdominal pain—Auranofin—psoriatic arthritis	0.00912	0.00912	CcSEcCtD
Nalbuphine—Euphoric mood—Prednisolone—psoriatic arthritis	0.00886	0.00886	CcSEcCtD
Nalbuphine—Pulmonary oedema—Triamcinolone—psoriatic arthritis	0.00844	0.00844	CcSEcCtD
Nalbuphine—Pulmonary oedema—Methylprednisolone—psoriatic arthritis	0.00842	0.00842	CcSEcCtD
Nalbuphine—Pruritus—Auranofin—psoriatic arthritis	0.00816	0.00816	CcSEcCtD
Nalbuphine—Euphoric mood—Triamcinolone—psoriatic arthritis	0.00815	0.00815	CcSEcCtD
Nalbuphine—Euphoric mood—Methylprednisolone—psoriatic arthritis	0.00813	0.00813	CcSEcCtD
Nalbuphine—Pulmonary oedema—Dexamethasone—psoriatic arthritis	0.00766	0.00766	CcSEcCtD
Nalbuphine—Pulmonary oedema—Betamethasone—psoriatic arthritis	0.00766	0.00766	CcSEcCtD
Nalbuphine—Euphoric mood—Dexamethasone—psoriatic arthritis	0.00739	0.00739	CcSEcCtD
Nalbuphine—Euphoric mood—Betamethasone—psoriatic arthritis	0.00739	0.00739	CcSEcCtD
Nalbuphine—Vomiting—Auranofin—psoriatic arthritis	0.00734	0.00734	CcSEcCtD
Nalbuphine—Speech disorder—Methotrexate—psoriatic arthritis	0.00728	0.00728	CcSEcCtD
Nalbuphine—Rash—Auranofin—psoriatic arthritis	0.00728	0.00728	CcSEcCtD
Nalbuphine—Dermatitis—Auranofin—psoriatic arthritis	0.00727	0.00727	CcSEcCtD
Nalbuphine—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00712	0.00712	CcSEcCtD
Nalbuphine—Nausea—Auranofin—psoriatic arthritis	0.00685	0.00685	CcSEcCtD
Nalbuphine—Pulmonary oedema—Prednisone—psoriatic arthritis	0.00667	0.00667	CcSEcCtD
Nalbuphine—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.00655	0.00655	CcSEcCtD
Nalbuphine—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.00653	0.00653	CcSEcCtD
Nalbuphine—Euphoric mood—Prednisone—psoriatic arthritis	0.00644	0.00644	CcSEcCtD
Nalbuphine—Sweating increased—Prednisolone—psoriatic arthritis	0.0063	0.0063	CcSEcCtD
Nalbuphine—Asthma—Triamcinolone—psoriatic arthritis	0.00595	0.00595	CcSEcCtD
Nalbuphine—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00594	0.00594	CcSEcCtD
Nalbuphine—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00594	0.00594	CcSEcCtD
Nalbuphine—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00584	0.00584	CcSEcCtD
Nalbuphine—Sweating increased—Triamcinolone—psoriatic arthritis	0.0058	0.0058	CcSEcCtD
Nalbuphine—Sweating increased—Methylprednisolone—psoriatic arthritis	0.00578	0.00578	CcSEcCtD
Nalbuphine—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.00557	0.00557	CcSEcCtD
Nalbuphine—Bradycardia—Prednisolone—psoriatic arthritis	0.00527	0.00527	CcSEcCtD
Nalbuphine—Sweating increased—Dexamethasone—psoriatic arthritis	0.00526	0.00526	CcSEcCtD
Nalbuphine—Sweating increased—Betamethasone—psoriatic arthritis	0.00526	0.00526	CcSEcCtD
Nalbuphine—Cardiac arrest—Prednisone—psoriatic arthritis	0.00517	0.00517	CcSEcCtD
Nalbuphine—Bradycardia—Triamcinolone—psoriatic arthritis	0.00485	0.00485	CcSEcCtD
Nalbuphine—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00484	0.00484	CcSEcCtD
Nalbuphine—Hallucination—Methylprednisolone—psoriatic arthritis	0.00473	0.00473	CcSEcCtD
Nalbuphine—Sweating increased—Prednisone—psoriatic arthritis	0.00458	0.00458	CcSEcCtD
Nalbuphine—Erythema—Prednisolone—psoriatic arthritis	0.00451	0.00451	CcSEcCtD
Nalbuphine—Bradycardia—Dexamethasone—psoriatic arthritis	0.0044	0.0044	CcSEcCtD
Nalbuphine—Bradycardia—Betamethasone—psoriatic arthritis	0.0044	0.0044	CcSEcCtD
Nalbuphine—Hallucination—Betamethasone—psoriatic arthritis	0.0043	0.0043	CcSEcCtD
Nalbuphine—Hallucination—Dexamethasone—psoriatic arthritis	0.0043	0.0043	CcSEcCtD
Nalbuphine—Vision blurred—Prednisolone—psoriatic arthritis	0.00425	0.00425	CcSEcCtD
Nalbuphine—Depression—Prednisone—psoriatic arthritis	0.00418	0.00418	CcSEcCtD
Nalbuphine—Erythema—Triamcinolone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Nalbuphine—Erythema—Methylprednisolone—psoriatic arthritis	0.00414	0.00414	CcSEcCtD
Nalbuphine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00406	0.00406	CcSEcCtD
Nalbuphine—Vertigo—Prednisolone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Nalbuphine—Syncope—Prednisolone—psoriatic arthritis	0.00404	0.00404	CcSEcCtD
Nalbuphine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00396	0.00396	CcSEcCtD
Nalbuphine—Asthma—Methotrexate—psoriatic arthritis	0.00393	0.00393	CcSEcCtD
Nalbuphine—Convulsion—Prednisolone—psoriatic arthritis	0.00391	0.00391	CcSEcCtD
Nalbuphine—Hypertension—Prednisolone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Nalbuphine—Bradycardia—Prednisone—psoriatic arthritis	0.00383	0.00383	CcSEcCtD
Nalbuphine—Erythema—Betamethasone—psoriatic arthritis	0.00376	0.00376	CcSEcCtD
Nalbuphine—Erythema—Dexamethasone—psoriatic arthritis	0.00376	0.00376	CcSEcCtD
Nalbuphine—Hallucination—Prednisone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Nalbuphine—Vertigo—Triamcinolone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Nalbuphine—Syncope—Triamcinolone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Nalbuphine—Vertigo—Methylprednisolone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Nalbuphine—Syncope—Methylprednisolone—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Nalbuphine—Oedema—Prednisolone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Nalbuphine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Nalbuphine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Nalbuphine—Shock—Prednisolone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Nalbuphine—Convulsion—Triamcinolone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Nalbuphine—Tachycardia—Prednisolone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Nalbuphine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Nalbuphine—Hypertension—Triamcinolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Nalbuphine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Nalbuphine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00351	0.00351	CcSEcCtD
Nalbuphine—Depression—Methotrexate—psoriatic arthritis	0.00349	0.00349	CcSEcCtD
Nalbuphine—Flushing—Prednisone—psoriatic arthritis	0.00349	0.00349	CcSEcCtD
Nalbuphine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Nalbuphine—Confusional state—Methylprednisolone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Nalbuphine—Oedema—Triamcinolone—psoriatic arthritis	0.00338	0.00338	CcSEcCtD
Nalbuphine—Vertigo—Dexamethasone—psoriatic arthritis	0.00338	0.00338	CcSEcCtD
Nalbuphine—Vertigo—Betamethasone—psoriatic arthritis	0.00338	0.00338	CcSEcCtD
Nalbuphine—Syncope—Betamethasone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Nalbuphine—Syncope—Dexamethasone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Nalbuphine—Shock—Triamcinolone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Nalbuphine—Shock—Methylprednisolone—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Nalbuphine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Nalbuphine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisolone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Nalbuphine—Tachycardia—Triamcinolone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Nalbuphine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Nalbuphine—Erythema—Prednisone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Nalbuphine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Nalbuphine—Convulsion—Dexamethasone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Nalbuphine—Convulsion—Betamethasone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Nalbuphine—Hypertension—Betamethasone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Nalbuphine—Hypertension—Dexamethasone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Nalbuphine—Anxiety—Dexamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Nalbuphine—Anxiety—Betamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Nalbuphine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Nalbuphine—Vision blurred—Prednisone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Nalbuphine—Oedema—Betamethasone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Nalbuphine—Oedema—Dexamethasone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Nalbuphine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Nalbuphine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Nalbuphine—Shock—Betamethasone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Nalbuphine—Shock—Dexamethasone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Nalbuphine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Nalbuphine—Agitation—Prednisone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Nalbuphine—Tachycardia—Dexamethasone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Nalbuphine—Tachycardia—Betamethasone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Nalbuphine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Nalbuphine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Nalbuphine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Nalbuphine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Nalbuphine—Vertigo—Prednisone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Nalbuphine—Syncope—Prednisone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Nalbuphine—Urticaria—Prednisolone—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Nalbuphine—Loss of consciousness—Prednisone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Nalbuphine—Hypotension—Betamethasone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Nalbuphine—Hypotension—Dexamethasone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Nalbuphine—Convulsion—Prednisone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Nalbuphine—Hypertension—Prednisone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Nalbuphine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Nalbuphine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Nalbuphine—Anxiety—Prednisone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Nalbuphine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Nalbuphine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Nalbuphine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Nalbuphine—Dyspepsia—Betamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Nalbuphine—Urticaria—Triamcinolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Nalbuphine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Nalbuphine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Nalbuphine—Oedema—Prednisone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Nalbuphine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Nalbuphine—Shock—Prednisone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Nalbuphine—Tachycardia—Prednisone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Nalbuphine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Nalbuphine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Nalbuphine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Nalbuphine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Nalbuphine—Urticaria—Betamethasone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Nalbuphine—Urticaria—Dexamethasone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Nalbuphine—Dizziness—Prednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Nalbuphine—Asthenia—Triamcinolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Nalbuphine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Nalbuphine—Abdominal pain—Betamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Nalbuphine—Body temperature increased—Betamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Nalbuphine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Nalbuphine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Nalbuphine—Pruritus—Triamcinolone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Nalbuphine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Nalbuphine—Dyspepsia—Prednisone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Nalbuphine—Rash—Prednisolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Nalbuphine—Dermatitis—Prednisolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Nalbuphine—Headache—Prednisolone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Nalbuphine—Dizziness—Triamcinolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Nalbuphine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Nalbuphine—Asthenia—Betamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Nalbuphine—Asthenia—Dexamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Nalbuphine—Nausea—Prednisolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Nalbuphine—Pruritus—Dexamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Nalbuphine—Pruritus—Betamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Nalbuphine—Vomiting—Triamcinolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Nalbuphine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Nalbuphine—Rash—Triamcinolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Nalbuphine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Nalbuphine—Rash—Methylprednisolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Nalbuphine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Nalbuphine—Urticaria—Prednisone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Nalbuphine—Headache—Triamcinolone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Nalbuphine—Headache—Methylprednisolone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Nalbuphine—Abdominal pain—Prednisone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Nalbuphine—Body temperature increased—Prednisone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Nalbuphine—Dizziness—Dexamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Nalbuphine—Dizziness—Betamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Nalbuphine—Nausea—Triamcinolone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Nalbuphine—Nausea—Methylprednisolone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Nalbuphine—Vomiting—Betamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Nalbuphine—Vomiting—Dexamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Nalbuphine—Rash—Dexamethasone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Nalbuphine—Rash—Betamethasone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Nalbuphine—Dermatitis—Betamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Nalbuphine—Dermatitis—Dexamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Nalbuphine—Headache—Betamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Nalbuphine—Headache—Dexamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Nalbuphine—Asthenia—Prednisone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Nalbuphine—Pruritus—Prednisone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Nalbuphine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Nalbuphine—Nausea—Betamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Nalbuphine—Nausea—Dexamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Nalbuphine—Urticaria—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Nalbuphine—Dizziness—Prednisone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Nalbuphine—Vomiting—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Nalbuphine—Rash—Prednisone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Nalbuphine—Dermatitis—Prednisone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Nalbuphine—Headache—Prednisone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Nalbuphine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Nalbuphine—Asthenia—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Nalbuphine—Nausea—Prednisone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Nalbuphine—Pruritus—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Nalbuphine—Dizziness—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Nalbuphine—Vomiting—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Nalbuphine—Rash—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Nalbuphine—Headache—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Nalbuphine—Nausea—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
